查詢結果分析
來源資料
相關文獻
- Efffect of Erythromycin on Feeding Intolerance in Very Low Birth Weight Infants: A Preliminary Observation
- Clinical Experience with Early Enteral Feeding in Very-Low-Birth-Weight Infants
- 極低出生體重早產兒之嬰兒再餵食症候群和臨床預後:ProVIDe trial次級世代研究分析
- The Use of Prophylactic Intravenous Immunoglobulin Therapy in Very Low Birthweight Infants
- Staphylococcus capitis Bacteremia of Very Low Birth Weight Premature Infants at Neonatal Intensive Care Units: Clinical Significance and Antimicrobial Susceptibility
- 早產兒居家餵食與睡眠
- The Anesthetic Management of A Preterm Infant Weighing 500 Grams Undergoing Ligation of Patent Ductus Arteriosus--A Case Report
- Glucose and Insulin Infusion Versus Kayexalate for the Early Treatment of Non-oliguric Hyperkalemia in Very-Low-Birth-Weight Infants
- Intractable Wheezing and Swallowing Problem in an Infant: Report of One Case
- 早產兒餵食前吸吮安撫奶嘴對行為狀態及餵食影響之探討
頁籤選單縮合
題 名 | Efffect of Erythromycin on Feeding Intolerance in Very Low Birth Weight Infants: A Preliminary Observation=紅黴素在極低體重早產兒的餵食: 初報 |
---|---|
作 者 | 蘇百弘; 林鴻志; 彭慶添; 蔡長海; | 書刊名 | 中華民國小兒科醫學會雜誌 |
卷 期 | 39:5 民87.09-10 |
頁 次 | 頁324-326 |
分類號 | 417.5171 |
關鍵詞 | 紅黴素; 餵食; 極低體重早產兒; Erythromycin; Feeding intolerance; Very low birth weight infant; |
語 文 | 英文(English) |
中文摘要 | 為了解紅黴素對極低體重早產兒之腸道餵食不耐症的作用,從1997年2月到12 月,有20個體重小於1500公克患有長期腸道餵食不耐症的早產兒做為研究對象。紅黴素投 予的方法為:負荷劑量30mg/kg/日連續三天,每天分為三次,每次靜脈輸注時間1小時,然 後改為維持劑量3~5mg/kg/日,每天一次靜脈輸注1小時,直到腸道餵食能完全建立為止。 紅黴素的療效是以每日胃管出入量的淨值(胃管灌食量-胃管反抽量)來評估。20個早產兒的 平均懷孕週數為27.12.0週,平均出生體重為1025±196公克。開始投予紅黴素的平均日齡 為生後19.5±14日,紅黴素投予後2.4±1.1天可開始胃管餵食,15.1±2.2天後腸道餵食得 以完全建立。紅黴素投予開始時的胃管出入量的淨值為-4.8±4.1ml,投予後第七天為 30.6±15.3ml,第14天時為92.6±25.4ml,第21天為125.3±18.1ml。這個研究顯示,使用紅 黴素能安全地改善極低體重早產兒的長期腸道餵食不耐症。我們建議以進一步對照研究的結 果來確認紅黴素對胃腸道活動力的影響及效果。 |
英文摘要 | To investigate the effect of erythromycin on feeding intolerance in very low birth weight infants, from February 1997 to December 1997 twenty infants weighing less than 1500 g, with prolonged intolerance of enteral feeding, were enrolled in this study. The protocol for erythromycin treatment was: a loading dose of 30 mg/kg/day, divided into three portions given every eight hours intravenously for 1 hour over a three day period; then a maintenance dose of 3~5 mg/kg intravenously for one hour once a day was given until full feeding was well established. The assessment of erythromycin effect was the daily net orogastric balance (volume of orogastric tube feeding minus volume of orogastric aspirates). The mean gestational age was 27.1 ±2.0 weeks (mean ± SD) and the mean birth weight was 1025 ±196 g. The mean age when erythromycin started was 19.5±14 days; the mean days after the initiation of erythromycin when orogastric tube feeding could be started and full feeding established were 2.4±1.1 days and 15.1±2.2 days, respectively. At the beginning of erythromycin treatment, the net balance of tube aspirates was -4.8 ±4.1 ml. The net balance rose significantly to 30.6 ±15.3 ml, 92.6±25.4 ml and 125.3 ±18.1 ml at 7, 14 and 21 days after erythromycin treatment respectively. In conclusion, erythromycin treatment is a safe method to improve intolerance of enteral feeding in very low birth weight infants. It is suggested that the effect of erythromycin on gastrointestinal motility in these infants should be further investigated in the context of a randomized, controlled trial before widespread clinical implementation of this treatment. |
本系統中英文摘要資訊取自各篇刊載內容。